Fungal Infections (FI) Associated with Covid-19

The aim of this study was to conduct a survey of the fungal species associated with COVID-19 viral infection in 150 patients who were admitted to the intensive care unit (ICU) in Al-Diwaniyah Teaching Hospital in Al-Diwaniyah City, Iraq, for a five-month period from October 2021 to February 2022. The results indicated the dominance of Candida spp. over the rest of the isolated fungal species, with 97 isolates (64.66%). Aspergillus spp., with 15 isolates (10%), came in second. Rhizopus sp. with 2 isolates (1.33%). Then with 1 isolate (0.66%) for each of Penicillium sp., Coccidiodes sp., and Rhodotorula sp., Also, results show that the male has a higher percentage than the female (54.9%) and co-infections with fungi were more common in the 60-69 age group then in the 70-79 age group (34% versus 24%, respectively). Taking a deeper look at the patients' medical histories, it was shown that fungal co-infection was more prevalent in those with chronic sickness than in those without chronic disease (55.66% versus 43.14%, respectively).Copyright © RJPT All right reserved.

Filamentous fungi associated with COVID-19 and its susceptibility to some antifungals

The purpose of this study was to conduct a survey of the fungal species associated with COVID-19 viral infection in 150 patients who were admitted to the intensive care unit (ICU) in Al-Diwaniyah Teaching Hospital in Al-Diwaniyah City, Iraq, for a period of five months beginning in October 2021 and ending in February 2022. The survey was to be conducted over the course of the period from October 2021 to February 2022. According to the findings, yeasts were more prevalent than any of the other detected fungal species, accounting for 98 of the total isolates (65.33 percent). While filamentous fungus accounted for 19 isolates (12.33 percent), including the predominance of Aspergillus flavus with 6 isolates (40 percent) in comparison to the Aspergillus spp. ratio, these fungi were found to be rather uncommon. In light of the fact that this publication provided evidence of the isolation of Aspergillus sydowii from COVID19 patients for the first time anywhere in the world: In addition, we drew attention to the outstanding activity of the antifungal medications amphotericin B, itraconazole, and voriconazole, all of which have a high susceptibility rate. © 2022 International Journal of Health Sciences.All rights reserved.